Invention Grant
US08163276B2 Systems and methods for isolating and using clinically safe adipose derived regenerative cells
有权
用于分离和使用临床安全的脂肪来源的再生细胞的系统和方法
- Patent Title: Systems and methods for isolating and using clinically safe adipose derived regenerative cells
- Patent Title (中): 用于分离和使用临床安全的脂肪来源的再生细胞的系统和方法
-
Application No.: US12554755Application Date: 2009-09-04
-
Publication No.: US08163276B2Publication Date: 2012-04-24
- Inventor: Marc H. Hedrick , John K. Fraser , Michael J. Schulzki , Bobby Byrnes , Grace Carlson , Ronda Schreiber , Isabella Wulur
- Applicant: Marc H. Hedrick , John K. Fraser , Michael J. Schulzki , Bobby Byrnes , Grace Carlson , Ronda Schreiber , Isabella Wulur
- Applicant Address: US CA San Diego
- Assignee: Cytori Therapeutics, Inc.
- Current Assignee: Cytori Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Knobbe Martens Olson & Bear LLP
- Main IPC: C12N5/00
- IPC: C12N5/00
Abstract:
Systems and methods are described that are used to separate cells from a wide variety of tissues. In particular, automated systems and methods are described that separate regenerative cells, e.g., stem and/or progenitor cells, from adipose tissue. The systems and methods described herein provide rapid and reliable methods of separating and concentrating regenerative cells suitable for re-infusion into a subject.
Public/Granted literature
- US20100136668A1 SYSTEMS AND METHODS FOR ISOLATING AND USING CLINICALLY SAFE ADIPOSE DERIVED REGENERATIVE CELLS Public/Granted day:2010-06-03
Information query
